RESIST: Understanding the Role of Depression in Heart Disease

NCT02657798 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2020-03-26

No results posted yet for this study

Summary

This study will investigate the biological pathways involved in anti-depressant resistance that increase risk of cardiovascular disease in people with depression.

Conditions

Sponsors & Collaborators

  • British Heart Foundation

    collaborator OTHER
  • University College, London

    lead OTHER

Principal Investigators

  • Glyn Lewis · UCL

Eligibility

Min Age
18 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-12-31
Completion
2018-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02657798 on ClinicalTrials.gov